Stay updated on Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial

Sign up to get notified when there's something new on the Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.3.4 updated in the page history (replacing v3.3.3).
    Difference
    0.1%
    Check dated 2026-01-14T00:40:46.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    A new revision entry (v3.3.3) was added to the record history for NCT04249362, and the HHS Vulnerability Disclosure link was removed from the footer.
    Difference
    0.1%
    Check dated 2025-12-23T09:12:59.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    New Revision: v3.3.2 appears in the history, replacing v3.3.1; this reflects a site update with no changes to trial data or history content.
    Difference
    0.1%
    Check dated 2025-12-01T16:39:50.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The only change is the addition of a site revision label 'Revision: v3.3.1' and the removal of 'Revision: v3.2.0'. There are no changes to study records, statuses, or patient-facing content; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T11:54:11.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Removed a general government funding/operating status notice that was displayed at the top of the page; the rest of the trial record content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-17T06:17:25.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The old and new screenshots display the same Version History and study status sections with no substantive updates; changes are limited to formatting and layout.
    Difference
    0.1%
    Check dated 2025-11-03T00:51:45.000Z thumbnail image

Stay in the know with updates to Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial page.